Advertisement

Sickle Cell Retinopathy

  • Ru-ik Chee
  • Sarwar Zahid
  • Jennifer I. LimEmail author
Chapter
  • 41 Downloads
Part of the Retina Atlas book series (RA)

Abstract

Sickle cell disease refers to a group of inherited hemoglobinopathies characterized by abnormal hemoglobin genes. The resulting abnormal hemoglobin protein results in sickling of erythrocytes, intravascular hemolysis, defective oxygen transport, and tissue damage due to ischemia and necrosis. Sickle cell disease manifests systemically in many organs such as the brain, lungs, heart, liver, spleen, kidneys, joints, bones, and skin (Yawn et al. 2014).

Notes

Acknowledgments

The authors would like to thank Mark Janowicz, Principal Ophthalmic Photographer at Illinois Eye and Ear Infirmary, University of Illinois at Chicago, for his expertise with the acquisition of images in this chapter.

References

  1. Alam M, Thapa D, Lim JI, et al. Quantitative characteristics of sickle cell retinopathy in optical coherence tomography angiography. Biomed Opt Express. 2017;8:1741–53.CrossRefGoogle Scholar
  2. Chen RWS, Flynn HW, Lee W-H, et al. Vitreoretinal management and surgical outcomes in proliferative sickle retinopathy: a case series. Am J Ophthalmol. 2014;157:870–5.e1.CrossRefGoogle Scholar
  3. Cho M, Kiss S. Detection and monitoring of sickle cell retinopathy using ultra wide-field color photography and fluorescein angiography. Retina. 2011;31:738–47.CrossRefGoogle Scholar
  4. Chow CC, Genead MA, Anastasakis A, et al. Structural and functional correlation in sickle cell retinopathy using spectral-domain optical coherence tomography and scanning laser ophthalmoscope microperimetry. Am J Ophthalmol. 2011;152:704–11.e2.CrossRefGoogle Scholar
  5. Chow CC, Shah RJ, Lim JI, et al. Peripapillary retinal nerve fiber layer thickness in sickle-cell hemoglobinopathies using spectral-domain optical coherence tomography. Am J Ophthalmol. 2013;155:456–64.e2.CrossRefGoogle Scholar
  6. Condon PI, Serjeant GR. Behaviour of untreated proliferative sickle retinopathy. Br J Ophthalmol. 1980;64:404–11.CrossRefGoogle Scholar
  7. Estepp JH, Smeltzer MP, Wang WC, et al. Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children. Br J Haematol. 2013;161:402–5.CrossRefGoogle Scholar
  8. Fox PD, Dunn DT, Morris JS, Serjeant GR. Risk factors for proliferative sickle retinopathy. Br J Ophthalmol. 1990;74:172–6.CrossRefGoogle Scholar
  9. Ghasemi Falavarjani K, Scott AW, Wang K, et al. Correlation of multimodal imaging in sickle cell retinopathy. Retina. 2016;36(Suppl 1):S111–7.CrossRefGoogle Scholar
  10. Gill HS, Lam W-C. A screening strategy for the detection of sickle cell retinopathy in pediatric patients. Can J Ophthalmol. 2008;43:188–91.CrossRefGoogle Scholar
  11. Goldberg MF. Retinal neovascularization in sickle cell retinopathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83:OP409–31.PubMedGoogle Scholar
  12. Grover S, Sambhav K, Chalam KV. Capillary nonperfusion by novel technology of OCT angiography in a patient with sickle cell disease with normal fluorescein angiogram. Eur J Ophthalmol. 2016;26:e121–3.CrossRefGoogle Scholar
  13. Hayes RJ, Condon PI, Serjeant GR. Haematological factors associated with proliferative retinopathy in homozygous sickle cell disease. Br J Ophthalmol. 1981;65:29–35.CrossRefGoogle Scholar
  14. Hoang QV, Chau FY, Shahidi M, Lim JI. Central macular splaying and outer retinal thinning in asymptomatic sickle cell patients by spectral-domain optical coherence tomography. Am J Ophthalmol. 2011;151:990–4.e1.CrossRefGoogle Scholar
  15. Lim JI. Ophthalmic manifestations of sickle cell disease: update of the latest findings. Curr Opin Ophthalmol. 2012;23:533–6.CrossRefGoogle Scholar
  16. Lim JI, Cao D. Analysis of retinal thinning using spectral-domain optical coherence tomography imaging of sickle cell retinopathy eyes compared to age- and race-matched control eyes. Am J Ophthalmol. 2018;192:229–38.Google Scholar
  17. Mitropoulos PG, Chatziralli IP, Parikakis EA, et al. Intravitreal ranibizumab for stage IV proliferative sickle cell retinopathy: a first case report. Case Rep Ophthalmol Med. 2014;2014:682583.PubMedPubMedCentralGoogle Scholar
  18. Moshiri A, Ha NK, Ko FS, Scott AW. Bevacizumab PRESURGICAL treatment for proliferative sickle-cell retinopathy-related retinal detachment. Retin Cases Brief Rep. 2013;7:204–5.CrossRefGoogle Scholar
  19. Paton D. Angiod streaks and sickle cell anemia: a report of two cases. Arch Ophthalmol. 1959;62:852–8.CrossRefGoogle Scholar
  20. Romayanada N, Goldberg MF, Green WR. Histopathology of sickle cell retinopathy. Trans Am Acad Ophthalmol Otolaryngol. 1973;77:OP642–76.Google Scholar
  21. Ryan SJ, Goldberg MF. Anterior segment ischemia following scleral buckling in sickle cell hemoglobinopathy. Am J Ophthalmol. 1971;72:35–50.CrossRefGoogle Scholar
  22. Shaikh S. Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy. Indian J Ophthalmol. 2008;56:259.CrossRefGoogle Scholar
  23. Siqueira RC, Costa RA, Scott IU, et al. Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy. Acta Ophthalmol Scand. 2006;84:834–5.CrossRefGoogle Scholar
  24. Walton W, Von Hagen S, Grigorian R, Zarbin M. Management of traumatic hyphema. Surv Ophthalmol. 2002;47:297–334.CrossRefGoogle Scholar
  25. Williamson TH, Rajput R, Laidlaw DAH, Mokete B. Vitreoretinal management of the complications of sickle cell retinopathy by observation or pars plana vitrectomy. Eye. 2009;23:1314–20.CrossRefGoogle Scholar
  26. Witkin AJ. Optical coherence tomography demonstration of macular infarction in sickle cell retinopathy. Arch Ophthalmol. 2006;124:746.CrossRefGoogle Scholar
  27. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312:1033–48.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.Department of Ophthalmology and Visual SciencesUniversity of Illinois at ChicagoChicagoUSA

Personalised recommendations